SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-12-056975
Filing Date
2012-08-10
Accepted
2012-08-10 15:44:59
Documents
5
Group Members
NOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-17799_1sc13da.htm SC 13D/A 227353
2 EX-2 a12-17799_1ex2.htm EX-2 941659
3 EX-3 a12-17799_1ex3.htm EX-3 23119
4 EX-4 a12-17799_1ex4.htm EX-4 4833
5 EX-5 a12-17799_1ex5.htm EX-5 3248
  Complete submission text file 0001104659-12-056975.txt   1201836
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Subject) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79969 | Film No.: 121024529
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations